Angle (United Kingdom) Overview

  • Founded
  • 1994
Founded
  • Status
  • Public
  • Employees
  • 97
Employees
  • Stock Symbol
  • AGL
Stock Symbol
  • Investments
  • 10
  • Share Price
  • $1.63
  • (As of Friday Closing)

Angle (United Kingdom) General Information

Description

ANGLE PLC is active in the healthcare sector in the United Kingdom. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology has the potential to treat and diagnose the various forms of cancer. The Parsortix system can capture and harvest (Circulating Tumor Cells)CTCs from patient blood. Its geographical segments include Europe and North America, of which the majority of the revenue is generated from Europe.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
LON
Primary Office
  • 10 Nugent Road
  • Surrey Research Park
  • Guildford GU2 7AF
  • England, United Kingdom
+44 01483 000000

Angle (United Kingdom) Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Angle (United Kingdom) Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.63 $1.59 $0.50 - $2.05 $374M 235M 497K -$0.08

Angle (United Kingdom) Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 30-Apr-2019 FY 2018 30-Apr-2018
EV 117,606 117,606 121,184 69,973
Revenue 977 977 884 839
EBITDA (15,899) (15,899) (12,815) (10,883)
Net Income (14,877) (14,877) (11,663) (10,099)
Total Assets 53,217 53,217 26,297 25,172
Total Debt 1,856 1,856 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Angle (United Kingdom) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Angle (United Kingdom)‘s full profile, request access.

Request a free trial

Angle (United Kingdom) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
ANGLE PLC is active in the healthcare sector in the United Kingdom. It is a medical diagnostic company specializing in t
Biotechnology
Guildford, United Kingdom
97 As of 2020
00000
000000000 00000

00000000

d do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostr
0000 000000000
Menlo Park, CA
000 As of 0000
00000
0000 0000-00-00
00000000 00000

000000

idunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco l
0000 000000000
Cambridge, MA
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Angle (United Kingdom) Competitors (19)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Personalis Formerly VC-backed Menlo Park, CA 000 00000 00000000 00000
000000 Formerly VC-backed Cambridge, MA 000 00000 00000000 00000
0000000 0000000000 Corporation Emeryville, CA 000 00000 000000000 00000
000000 00000000000 Corporation Plymouth Meeting, PA 000 000.00 00000000 000.00
000000000 00000000 Venture Capital-Backed Rockville, MD 0 000.00 0000000000 0 000.00
You’re viewing 5 of 19 competitors. Get the full list »

Angle (United Kingdom) Executive Team (20)

Name Title Board Seat Contact Info
Andrew Newland Chief Executive Officer & Board Member
Ian Griffiths Chief Financial Officer, Finance & Board Member
Martin Cooke Principal Consultant
Michael O'Brien Business Development Director
Craig Miller Clinical Studies Director
You’re viewing 5 of 20 executive team members. Get the full list »

Angle (United Kingdom) Board Members (5)

Name Representing Role Since
000000 0000000 Angle (United Kingdom) Chief Executive Officer & Board Member 000 0000
00000 0000000 Angle (United Kingdom) Board Member 000 0000
00000 000000 Angle (United Kingdom) Chairman & Board Member 000 0000
000 000000000 Angle (United Kingdom) Chief Financial Officer, Finance & Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

Angle (United Kingdom) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Angle (United Kingdom) Investments & Acquisitions (10)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 00000 000000 05-Nov-2018 000000000 00000000 Diagnostic Equipment 000000 0000000
00000 01-Nov-2017 000000000000000000 00.000 Biotechnology 000000 0000000
00000 00000 000000 05-Oct-2011 000000000000000000 Diagnostic Equipment 000000 0000000
0000 00000 04-Apr-2006 00000 00000 00 00.00 Other Healthcare Technology Systems
Acolyte Biomedica 30-Sep-2004 Early Stage VC 00.00 Other Healthcare Technology Systems
You’re viewing 5 of 10 investments and acquisitions. Get the full list »

Angle (United Kingdom) Subsidiaries (2)

Company Name Industry Location Founded
ANGLE North America Diagnostic Equipment Philadelphia, PA 2006
00000 Biotechnology Toronto, Canada 0000
To view Angle (United Kingdom)’s complete subsidiaries history, request access »

Angle (United Kingdom) Exits (6)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 00000 04-Apr-2006 00000 00000 00 00.00 Completed
  • 4 buyers
0000000 000000000 30-Sep-2004 00000 00000 00 00.00 Completed
  • 4 buyers
0000000000 01-Jan-2004 00000000 00000000 Completed
  • 00000 (000000 0000
0000000 000000000 01-Jan-1999 00000 00000 00 Completed
  • 00000 (000000 0000
NeuroTargets 01-Jan-1999 Early Stage VC Completed
You’re viewing 5 of 6 exits. Get the full list »